Come up with a name for your new list and we'll add to it:
Juvaris BioTherapeutics raised a round of funding on November 09, 2007. Investors include
Kleiner Perkins Caufield & Byers.
Juvaris BioTherapeutics, Inc. is developing adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The Company's platform technology induces immunostimulation via cationic…